{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "BHVN",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 316727000
            },
            {
                "label": "Prepaid Expense and Other Assets, Current [Abstract]",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 11554000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 328281000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 8152000
            },
            {
                "label": "Equity Method Investments, Including Related Impairment",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 5338000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssets",
                "unit": "usd",
                "value": 2493000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 344264000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 14071000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 52102000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 66173000
            },
            {
                "label": "Liability related to sale of future royalties, net",
                "concept": "bhvn:LiabilityForSaleOfFutureRoyaltiesCarryingAmountNet",
                "unit": "usd",
                "value": 144111000
            },
            {
                "label": "Mandatorily redeemable preferred shares, net",
                "concept": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent",
                "unit": "usd",
                "value": 103646000
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 37690000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 68000
            },
            {
                "label": "Total current liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 351688000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, no par value; 200,000,000 shares authorized as of December\u00a031, 2019 and 2018; 52,385,283 and 44,197,549 shares issued and outstanding as of December\u00a031, 2019 and December\u00a031, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 881426000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 83523000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -972373000
            },
            {
                "label": "Total shareholders' equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -7424000
            },
            {
                "label": "Total liabilities and shareholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 344264000
            }
        ],
        "cf": [
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -528805000
            },
            {
                "label": "RSUs granted (in shares)",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 54972000
            },
            {
                "label": "Non-cash interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 12711000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 26580000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "bhvn:NoncashInterestExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Non-cash issuance of common shares as payment for license agreement",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 5646000
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": 3875000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of contingent equity liability",
                "concept": "bhvn:FairValueAdjustmentOfContingentEquityLiability",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -6076000
            },
            {
                "label": "Deferred tax assets",
                "concept": "IncreaseDecreaseInDeferredIncomeTaxes",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other non-cash items",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -646000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 3464000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": 232000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 3319000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 43320000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "IncreaseDecreaseInOtherNoncurrentLiabilities",
                "unit": "usd",
                "value": -1975000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -377331000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 2534000
            },
            {
                "label": "Purchase of equity method investment",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payments for leasehold improvements",
                "concept": "PaymentsForTenantImprovements",
                "unit": "usd",
                "value": 1250000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -3784000
            },
            {
                "label": "Proceeds from issuance of common shares",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 303221000
            },
            {
                "label": "Proceeds from sale of future royalties",
                "concept": "bhvn:ProceedsSaleOfFutureRoyaltiesNetOfIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of common stock related to sale of future royalties",
                "concept": "bhvn:ProceedsFromIssuanceOfCommonStockRelatedToSaleOfFutureRoyaltiesNetOfIssuanceCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from issuance of mandatorily redeemable preferred shares",
                "concept": "ProceedsFromIssuanceOfMandatoryRedeemableCapitalSecurities",
                "unit": "usd",
                "value": 125000000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 1998000
            },
            {
                "label": "Payments of related party notes payable",
                "concept": "RepaymentsOfRelatedPartyDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Repayment of notes payable",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Offering costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 1150000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 5524000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 434593000
            },
            {
                "label": "Net increase in cash and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 53478000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash paid for income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 823000
            },
            {
                "label": "Deferred offering costs included in accounts payable and accrued expenses",
                "concept": "bhvn:DeferredOfferingCostsIncludedInAccruedExpenses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Beneficial conversion feature on Series A convertible preferred shares",
                "concept": "bhvn:BeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accretion of beneficial conversion feature on Series A preferred shares",
                "concept": "bhvn:AccretionOfBeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Issuance of Series\u00a0A preferred shares as payment of offering costs",
                "concept": "bhvn:IssuanceOfSeriesPreferredStockAsPaymentOfOfferingCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Issuance of common shares as payment of equity investment",
                "concept": "bhvn:StockIssuedDuringPeriodValueEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of property and equipment under financing lease",
                "concept": "bhvn:PurchaseOfPropertyAndEquipmentUnderFinancingLease",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "Research and Development Costs",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 344673000
            },
            {
                "label": "General and administrative expenses",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 134449000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 479122000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -479122000
            },
            {
                "label": "Non-cash interest expense on mandatorily redeemable preferred shares",
                "concept": "InterestExpenseDebt",
                "unit": "usd",
                "value": 12711000
            },
            {
                "label": "Non-cash interest expense on liability related to sale of future royalties",
                "concept": "bhvn:NoncashInterestExpenseOnFutureRoyaltiesLiability",
                "unit": "usd",
                "value": 26580000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "bhvn:FairValueAdjustmentOfDerivativeLiability",
                "unit": "usd",
                "value": 3875000
            },
            {
                "label": "Change in fair value of contingent equity liability",
                "concept": "bhvn:FairValueAdjustmentOfContingentEquityLiabilityExcludingInitialCharge",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Loss from equity method investment",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -6076000
            },
            {
                "label": "Other",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -22000
            },
            {
                "label": "Total other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -49264000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -528386000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 419000
            },
            {
                "label": "Net loss and comprehensive loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -528805000
            },
            {
                "label": "Accretion of beneficial conversion feature on Series A preferred shares",
                "concept": "bhvn:AccretionOfBeneficialConversionFeatureValueConvertibleInstruments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd.",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -528805000
            },
            {
                "label": "Net loss per share attributable to common shareholders of Biohaven Pharmaceutical Holding Company Ltd. - basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -10.91
            },
            {
                "label": "Weighted average common shares outstanding - basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 48489890
            }
        ]
    }
}